| |
| |
|
| Insider
Information: |
Polaris Venture Partners Special Founders Fund V, |
| Relationship: |
10% Owner |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
9,634,076 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$12,760,958 |
|
|
| Total
Shares |
9,634,076 |
|
|
| Total
Value |
$12,760,958 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fate Therapeutics Inc |
FATE |
10% Owner |
2013-10-04 |
0 |
2013-10-04 |
2,473,186 |
Premium* |
|
|
Dare Bioscience Inc |
DARE |
10% Owner |
2014-04-15 |
0 |
2014-04-15 |
3,262,437 |
Premium* |
|
|
Ocular Therapeutix, Inc |
OCUL |
10% Owner |
2014-07-30 |
0 |
2015-02-02 |
19,588 |
Premium* |
|
|
Genocea Biosciences, Inc. |
GNCA |
10% Owner |
2014-08-08 |
0 |
2015-06-19 |
1,968,606 |
Premium* |
|
|
aTyr Pharma Inc |
LIFE |
10% Owner |
2015-05-12 |
0 |
2015-05-12 |
17,638 |
Premium* |
|
|
Pulmatrix Inc |
PULM |
10% Owner |
2015-06-15 |
0 |
2018-04-03 |
34,587 |
Premium* |
|
|
Selecta Biosciences Inc |
SELB |
10% Owner |
|
0 |
2016-06-27 |
1,836,703 |
Premium* |
|
|
Cardlytics Inc |
CDLX |
10% Owner |
2018-08-09 |
0 |
2019-07-17 |
21,331 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CDLX |
Cardlytics Inc |
10% Owner |
– – • |
2019-07-17 |
4 |
AS |
$27.45 |
$762,505 |
I/I |
(27,781) |
21,331 |
0 |
- |
|
| CDLX |
Cardlytics Inc |
10% Owner |
– – • |
2019-07-16 |
4 |
AS |
$27.87 |
$584,188 |
I/I |
(20,962) |
21,599 |
0 |
- |
|
| CDLX |
Cardlytics Inc |
10% Owner |
– – • |
2019-07-15 |
4 |
AS |
$27.73 |
$554,074 |
I/I |
(19,984) |
21,801 |
0 |
- |
|
| CDLX |
Cardlytics Inc |
10% Owner |
– – • |
2019-06-07 |
4 |
S |
$25.62 |
$2,562,120 |
I/I |
(100,000) |
21,994 |
0 |
- |
|
| CDLX |
Cardlytics Inc |
10% Owner |
– – • |
2019-06-06 |
4 |
S |
$25.00 |
$7,625 |
I/I |
(305) |
22,959 |
0 |
- |
|
| CDLX |
Cardlytics Inc |
10% Owner |
– – • |
2019-06-05 |
4 |
S |
$23.63 |
$959,507 |
I/I |
(38,601) |
22,962 |
0 |
- |
|
| CDLX |
Cardlytics Inc |
10% Owner |
– – • |
2019-06-04 |
4 |
S |
$23.28 |
$846,942 |
I/I |
(36,378) |
23,313 |
0 |
- |
|
| CDLX |
Cardlytics Inc |
10% Owner |
– – • |
2019-05-28 |
4 |
S |
$23.04 |
$2,303,810 |
I/I |
(100,000) |
23,664 |
0 |
- |
|
| CDLX |
Cardlytics Inc |
10% Owner |
– – • |
2018-09-13 |
4 |
S |
$25.52 |
$1,278,176 |
I/I |
(50,000) |
24,629 |
0 |
- |
|
| CDLX |
Cardlytics Inc |
10% Owner |
– – • |
2018-09-12 |
4 |
S |
$24.67 |
$2,478,105 |
I/I |
(100,000) |
25,111 |
0 |
- |
|
| CDLX |
Cardlytics Inc |
Director |
– • • |
2018-08-09 |
4 |
OE |
$0.00 |
$27 |
I/I |
66,364 |
26,076 |
0 |
- |
|
| PULM |
Pulmatrix Inc |
10% Owner |
– – • |
2018-04-03 |
4 |
B |
$0.00 |
$0 |
I/I |
1,150,000 |
34,587 |
1.42 |
- |
|
| SELB |
Selecta Biosciences Inc |
10% Owner |
– – • |
2016-06-27 |
4 |
B |
$14.00 |
$2,100,000 |
I/I |
150,000 |
1,836,703 |
1.5 |
- |
|
| SELB |
Selecta Biosciences Inc |
10% Owner |
– – • |
2016-06-27 |
4 |
A |
$0.00 |
$0 |
I/I |
1,712,695 |
1,691,963 |
0 |
- |
|
| SELB |
Selecta Biosciences Inc |
10% Owner |
– – • |
2016-06-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
40,742 |
|
- |
|
| GNCA |
Genocea Biosciences, Inc. |
10% Owner |
– – • |
2015-06-19 |
4 |
S |
$13.00 |
$13,000 |
I/I |
(1,000) |
1,968,606 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
10% Owner |
– – • |
2015-06-18 |
4 |
S |
$13.04 |
$378,212 |
I/I |
(29,004) |
1,969,606 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
10% Owner |
– – • |
2015-06-17 |
4 |
S |
$13.01 |
$138,140 |
I/I |
(10,618) |
1,998,610 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
10% Owner |
– – • |
2015-06-16 |
4 |
S |
$13.24 |
$609,040 |
I/I |
(46,000) |
2,009,228 |
0 |
- |
|
| PULM |
Pulmatrix Inc |
10% Owner |
– – • |
2015-06-15 |
4 |
B |
$6.88 |
$733,514 |
I/I |
106,693 |
52,692 |
1.5 |
- |
|
| PULM |
Pulmatrix Inc |
10% Owner |
– – • |
2015-06-15 |
4 |
A |
$0.00 |
$0 |
I/I |
3,923,539 |
51,330 |
0 |
- |
|
| PULM |
Pulmatrix Inc |
10% Owner |
– – • |
2015-06-15 |
4/A |
B |
$6.88 |
$508,998 |
I/I |
74,036 |
52,722 |
1.5 |
- |
|
| LIFE |
aTyr Pharma Inc |
10% Owner |
– – • |
2015-05-12 |
4 |
A |
$0.00 |
$0 |
I/I |
1,827,992 |
17,638 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
10% Owner |
– – • |
2015-02-02 |
4 |
S |
$29.50 |
$14,750,000 |
I/I |
(500,000) |
19,588 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
10% Owner |
– – • |
2014-08-14 |
4 |
S |
$13.01 |
$87,883 |
I/I |
(6,755) |
2,055,228 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
